The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Cifoban 136 mmol/l solution for infusion



Fresenius Medical Care Deutschland GmbHPA1350/008/001

Main Information

Trade NameCifoban 136 mmol/l solution for infusion
Active SubstancesTrisodium citrate dihydrate
Dosage FormSolution for injection
Licence HolderFresenius Medical Care Deutschland GmbH
Licence NumberPA1350/008/001

Group Information

ATC CodeB05ZB Hemofiltrates

Status

License statusAuthorised
Licence Issued28/01/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back